No Data
Express News | Aurinia Will Attend 2024 Jefferies Global Healthcare Conference
Shareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) Have Lost 64%, as Stock Drops 9.5% This Past Week
Retail Investors Who Hold 54% of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Gained 7.5%, Institutions Profited as Well
Key Insights Significant control over Aurinia Pharmaceuticals by retail investors implies that the general public has more power to influence management and governance-related decisions The top 25 s
Express News | Analysis Showing LUPKYNIS Is A Cost-Effective Treatment For Lupus Nephritis Presented At National Kidney Foundation's Spring Clinical Meeting 2024
Analysis Showing LUPKYNIS Is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation's Spring Clinical Meeting 2024
An updated analysis showed that LUPKYNIS is a cost-effective treatment for lupus nephritis, on par with other interventions for diabetes, blood pressure, and hyperlipidemia in adult patients with active lupus nephritis
Express News | Aurinia Reports Presentation Of Two Studies At The Annual Congress Of Clinical Rheumatology